Abstract:Various stresses, including pressure overload and myocardial stretch, can trigger cardiac remodeling and result in heart diseases. The disorders are associated with high risk of morbidity and mortality and are among the major health problems in the world. MicroRNAs, a class of ~22nt-long small non-coding RNAs, have been found to participate in regulating heart development and function. One of them, miR-208a, a cardiac-specific microRNA, plays key role(s) in modulating gene expression in the heart, and is involved in a broad array of processes in cardiac pathogenesis. Genetic deletion or pharmacological inhibition of miR-208a in rodents attenuated stress-induced cardiac hypertrophy and remodeling. Transgenic expression of miR-208a in the heart was sufficient to cause hypertrophic growth of cardiomyocytes. miR-208a is also a key regulator of cardiac conduction system, either deletion or transgenic expression of miR-208a disturbed heart electrophysiology and could induce arrhythmias. In addition, miR-208a appeared to assist in regulating the expression of fast- and slow-twitch myofiber genes in the heart. Notably, this heart-specific miRNA could also modulate the “endocrine” function of cardiac muscle and govern the systemic energy homeostasis in the whole body. Despite of the critical roles, the underlying regulatory networks involving miR-208a are still elusive. Here, we summarize the progress made in understanding the function and mechanisms of this important miRNA in the heart, and propose several topics to be resolved as well as the hypothetical answers. We speculate that miR-208a may play diverse and even opposite roles by being involved in distinct molecular networks depending on the contexts. A deeper understanding of the precise mechanisms of its action under the conditions of cardiac homeostasis and diseases is needed. The clinical implications of miR-208a are also discussed.

The Cell Type–Specific Functions of miR-21 in Cardiovascular Diseases

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

A Review of the Dual Role of MicroRNA-21 in Cardiovascular Diseases: Risk Factor or a Potential Therapeutic Target

Role and mechanism of miRNA in cardiac microvascular endothelial cells in cardiovascular diseases

[Research Progress on Mir-21 in Heart Diseases].

Small Molecules, Big Effects: the Role of Micrornas in Regulation of Cardiomyocyte Death

Subcellular microRNAs in diabetic cardiomyopathy

Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases

Role of miR-182 in cardiovascular and cerebrovascular diseases

Effect of Hypoxia-Induced MicroRNA-210 Expression on Cardiovascular Disease and the Underlying Mechanism

miR-208a in Cardiac Hypertrophy and Remodeling

Role of microRNA-21 in hypertrophic cardiac remodeling

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

The Emerging Role of MicroRNA-155 in Cardiovascular Diseases

Roles of MicroRNAs in Glucose and Lipid Metabolism in the Heart

Abstract P3023: The Regulatory Role Of Mir-21 In Heart Failure With Preserved Ejection Fraction (hfpef)

MicroRNA-21 Regulates Peroxisome Proliferator–activated Receptor Alpha, a Molecular Mechanism of Cardiac Pathology in Cardiorenal Syndrome Type 4

Recent advances in mechanistic studies of heart failure with preserved ejection fraction and its comorbidities-Role of microRNAs

The association between microRNA-21 and hypertension-induced cardiac remodeling

Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease

The double face of miR-320: cardiomyocytes-derived miR-320 deteriorated while fibroblasts-derived miR-320 protected against heart failure induced by transverse aortic constriction